Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Sterility Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Manufacturing Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Perspective (2018-2033)
2.2 Global Cell and Gene Therapy Manufacturing Quality Control Growth Trends by Region
2.2.1 Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Region (2018-2023)
2.2.3 Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Region (2024-2033)
2.3 Cell and Gene Therapy Manufacturing Quality Control Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Quality Control Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Quality Control Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Quality Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell and Gene Therapy Manufacturing Quality Control by Players
3.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2022
3.5 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Quality Control Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Type (2018-2023)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Type (2024-2033)
5 Cell and Gene Therapy Manufacturing Quality Control Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Application (2018-2023)
5.2 Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2033)
6.2 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
6.2.1 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
6.2.2 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
6.2.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
6.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
6.3.1 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
6.3.2 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
6.3.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
6.4 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
6.4.1 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
6.4.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2033)
7.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
7.2.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
7.2.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
7.2.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
7.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
7.3.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
7.3.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
7.3.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
7.4 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
7.4.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
7.4.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2033)
8.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
8.2.1 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
8.2.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
8.2.3 China Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
8.3 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
8.3.1 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
8.3.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
8.3.3 China Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2033)
9.2 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
9.2.1 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
9.2.2 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
9.2.3 Asia Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
9.3 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
9.3.1 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
9.3.2 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
9.3.3 Asia Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
9.4 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Region
9.4.1 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2023)
9.4.3 Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bio-Rad Laboratories,Inc.
11.1.1 Bio-Rad Laboratories,Inc. Company Details
11.1.2 Bio-Rad Laboratories,Inc. Business Overview
11.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.1.4 Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.1.5 Bio-Rad Laboratories,Inc. Recent Developments
11.2 QIAGEN
11.2.1 QIAGEN Company Details
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Introduction
11.2.4 QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.2.5 QIAGEN Recent Developments
11.3 Charles River Laboratories International, Inc.
11.3.1 Charles River Laboratories International, Inc. Company Details
11.3.2 Charles River Laboratories International, Inc. Business Overview
11.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.3.4 Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.3.5 Charles River Laboratories International, Inc. Recent Developments
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Details
11.4.2 Lonza Group AG Business Overview
11.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Introduction
11.4.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.4.5 Lonza Group AG Recent Developments
11.5 Bio-Techne Corporation
11.5.1 Bio-Techne Corporation Company Details
11.5.2 Bio-Techne Corporation Business Overview
11.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Introduction
11.5.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.5.5 Bio-Techne Corporation Recent Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Introduction
11.6.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.6.5 Merck KGaA Recent Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Details
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Ltd Recent Developments
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Details
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.8.5 Thermo Fisher Scientific, Inc. Recent Developments
11.9 Intertek Group Plc
11.9.1 Intertek Group Plc Company Details
11.9.2 Intertek Group Plc Business Overview
11.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Introduction
11.9.4 Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.9.5 Intertek Group Plc Recent Developments
11.10 Eurofins Scientific S.E.
11.10.1 Eurofins Scientific S.E. Company Details
11.10.2 Eurofins Scientific S.E. Business Overview
11.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.10.4 Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.10.5 Eurofins Scientific S.E. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Sterility Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Others
Table 7. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2018-2023)
Table 11. Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2024-2033)
Table 13. Cell and Gene Therapy Manufacturing Quality Control Market Trends
Table 14. Cell and Gene Therapy Manufacturing Quality Control Market Drivers
Table 15. Cell and Gene Therapy Manufacturing Quality Control Market Challenges
Table 16. Cell and Gene Therapy Manufacturing Quality Control Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Players (2018-2023)
Table 19. Global Top Cell and Gene Therapy Manufacturing Quality Control by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Quality Control as of 2022)
Table 20. Global Cell and Gene Therapy Manufacturing Quality Control Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing Quality Control Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Headquarters and Area Served
Table 23. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
Table 24. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Type (2018-2023)
Table 28. Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Type (2024-2033)
Table 30. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Application (2018-2023)
Table 32. Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Application (2024-2033)
Table 34. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Cell and Gene Therapy Manufacturing Quality Control Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Cell and Gene Therapy Manufacturing Quality Control Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Cell and Gene Therapy Manufacturing Quality Control Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033) & (US$ Million)
Table 66. Bio-Rad Laboratories,Inc. Company Details
Table 67. Bio-Rad Laboratories,Inc. Business Overview
Table 68. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 69. Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 70. Bio-Rad Laboratories,Inc. Recent Developments
Table 71. QIAGEN Company Details
Table 72. QIAGEN Business Overview
Table 73. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product
Table 74. QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 75. QIAGEN Recent Developments
Table 76. Charles River Laboratories International, Inc. Company Details
Table 77. Charles River Laboratories International, Inc. Business Overview
Table 78. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 79. Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 80. Charles River Laboratories International, Inc. Recent Developments
Table 81. Lonza Group AG Company Details
Table 82. Lonza Group AG Business Overview
Table 83. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product
Table 84. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 85. Lonza Group AG Recent Developments
Table 86. Bio-Techne Corporation Company Details
Table 87. Bio-Techne Corporation Business Overview
Table 88. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product
Table 89. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 90. Bio-Techne Corporation Recent Developments
Table 91. Merck KGaA Company Details
Table 92. Merck KGaA Business Overview
Table 93. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product
Table 94. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 95. Merck KGaA Recent Developments
Table 96. F. Hoffmann-La Roche Ltd Company Details
Table 97. F. Hoffmann-La Roche Ltd Business Overview
Table 98. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product
Table 99. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 100. F. Hoffmann-La Roche Ltd Recent Developments
Table 101. Thermo Fisher Scientific, Inc. Company Details
Table 102. Thermo Fisher Scientific, Inc. Business Overview
Table 103. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 104. Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 105. Thermo Fisher Scientific, Inc. Recent Developments
Table 106. Intertek Group Plc Company Details
Table 107. Intertek Group Plc Business Overview
Table 108. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product
Table 109. Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 110. Intertek Group Plc Recent Developments
Table 111. Eurofins Scientific S.E. Company Details
Table 112. Eurofins Scientific S.E. Business Overview
Table 113. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product
Table 114. Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 115. Eurofins Scientific S.E. Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Type: 2022 VS 2033
Figure 3. Sterility Testing Features
Figure 4. Purity Testing Features
Figure 5. Potency Testing Features
Figure 6. Identity Testing Features
Figure 7. Others Features
Figure 8. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application: 2022 VS 2033
Figure 10. Pharmaceutical & Biotechnology Companies Case Studies
Figure 11. Contract Manufacturing Organizations Case Studies
Figure 12. Cell and Gene Therapy Manufacturing Quality Control Report Years Considered
Figure 13. Global Cell and Gene Therapy Manufacturing Quality Control Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Cell and Gene Therapy Manufacturing Quality Control Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region: 2022 VS 2033
Figure 16. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Players in 2022
Figure 17. Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Quality Control as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2022
Figure 19. North America Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 21. North America Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 22. North America Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2018-2033)
Figure 23. United States Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 27. Europe Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 28. Europe Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2018-2033)
Figure 29. Germany Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Cell and Gene Therapy Manufacturing Quality Control Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 37. China Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 38. Asia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 40. Asia Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 41. Asia Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2018-2033)
Figure 42. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2018-2033)
Figure 52. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Bio-Rad Laboratories,Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 59. QIAGEN Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 60. Charles River Laboratories International, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 61. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 62. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 63. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 64. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 65. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 66. Intertek Group Plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 67. Eurofins Scientific S.E. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed